Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
ACAD ACADIA Pharmaceuticals
15.020
-0.090-0.60%
Symbol
ACAD
Company Name
ACADIA Pharmaceuticals
Listing Date
05/27/2004
Establishment Date
1993
CEO
Mr. Stephen R. Davis
Market
NASDAQ
Employees
514
Securities Type
DR
Fiscal Year Ends
12-31
Address
12830 El Camino Real,Suite 400
City
San Diego
Province
California
Country
United States of America
Zip code
92130-3331
Phone
1-858-558-2871
Profile
ACADIA Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on the development and commercialization of medicines to address unmet medical needs in central nervous system, or CNS, disorders. The firm's products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.
Company Overview
ACADIA Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on the development and commercialization of medicines to address unmet medical needs in central nervous system, or CNS, disorders. The firm's products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.
CEO: Mr. Stephen R. Davis
Market: NASDAQ
Listing Date: 05/27/2004
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist